BIO - BIO-RAD LABORATORIES, INC.
269.85
-9.180 -3.402%
Share volume: 275,802
Last Updated: 03-06-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$279.03
-9.18
-0.03%
Fundamental analysis
30%
Profitability
7%
Dept financing
35%
Liquidity
38%
Performance
49%
Performance
5 Days
-3.48%
1 Month
-8.49%
3 Months
-12.54%
6 Months
-7.07%
1 Year
3.32%
2 Year
-20.49%
Key data
Stock price
$269.85
DAY RANGE
$267.55 - $275.96
52 WEEK RANGE
$211.43 - $343.12
52 WEEK CHANGE
$8.92
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
Company detail
CEO: Norman D. Schwartz
Region: US
Website: bio-rad.com
Employees: 8,200
IPO year: 1980
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Region: US
Website: bio-rad.com
Employees: 8,200
IPO year: 1980
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.
Recent news